Engineers Gate Manager’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Buy
19,552
+10,282
+111% +$707K 0.02% 880
2026
Q1
$593K Buy
9,270
+3,810
+70% +$264K 0.01% 1315
2025
Q4
$434K Buy
+5,460
New +$461K 0.01% 1434
2025
Q2
Sell
-16,810
Closed -$834K 2346
2025
Q1
$834K Buy
16,810
+3,959
+31% +$220K 0.01% 1167
2024
Q4
$815K Buy
+12,851
New +$743K 0.01% 1129
2024
Q2
Sell
-4,560
Closed -$284K 2080
2024
Q1
$284K Sell
4,560
-6,867
-60% -$445K 0.01% 1489
2023
Q4
$660K Buy
+11,427
New +$585K 0.02% 1032
2022
Q1
Sell
-334
Closed -$29K 2074
2021
Q4
$29K Buy
+334
New +$32.7K ﹤0.01% 1917

Other funds holding IRON

Engineers Gate Manager's IRON Position: Q2 2026 in Review

Engineers Gate Manager increased its Disc Medicine (IRON) stake by 111% in Q2 2026, buying an estimated $707K and bringing the position to 19,552 shares worth $1.43M. The position accounts for 0.02% of the portfolio, ranked #880.

Engineers Gate Manager first reported a position in IRON in Q4 2021 and has held it in 8 quarters since. 217 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Engineers Gate Manager held 19,552 shares of Disc Medicine worth $1.43M as of Q2 2026.
  • Engineers Gate Manager bought 10,282 Disc Medicine shares in Q2 2026, an estimated $707K.
  • Disc Medicine made up 0.02% of Engineers Gate Manager's portfolio in Q2 2026, its #880 holding.
  • Engineers Gate Manager first reported a position in Disc Medicine in Q4 2021 and has held it in 8 quarters since.
  • 217 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.